search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
70 MARINE INGREDIENTS


Omega-3 Studies show how certain algae help mitigate common skin conditions linked to chronically inflamed skin. Bicoalgae ω3 is a natural origin omega-3 delivery system with targeted delivery of two microalgae extracts rich in omega-3 fatty acids. N. gaditana is a rich source of omega-3 EPA and I. galbana of omega-3 DHA. The natural origin omega-3 delivery system has a double encapsulation which stabilises the microalgae bioactives. It is clinically proven for barrier function, melanin reduction and other disorders related to chronically inflamed skin. Both endogenous and exogenous factors


may cause skin inflammation. When these elements are present, it affects the capacity of the body to respond against stressors. Oxidative stress from internal and external stressors leads to damaged cell and oxidised lipids the accumulation of. These trigger a chain reaction of events, leading to activation of macrophages. Macrophage activation triggers the release of ROS and pro- inflammatory cytokines, both associated with stimulating matrixmetallo-proteinases (MMPs) which cause degradation of the extracellular matrix (ECM), the epidermal-dermal junction (EDJ) and dermic proteins. ROS and cytokines continue to be released with continued exposure to skin stressors. Remaining in this state can cause damage that leads to skin disorders related to chronically inflamed skin. Microalgae are the primary source of omega-3 fatty acids EPA & DHA and they have an impact in several skin processes such as inflammatory conditions. Special pro-resolving mediators (SPMs) are


molecules with the potential to endogenously stimulate key cellular events in resolution of chronic inflammation.2,3


SPMs are


biosynthesised from the omega-3 essential fatty acids EPA and DHA4,5


6000.0 5000.0 4000.0 3000.0 2000.0 1000.0 0.0


Native not irradiated


Native UV-Vis irradiated


which can be found CONTROL


NOT IRRADIATED NOT TREATED


CONTROL


BLUE LIGHT IRRADIATED NOT TREATED


BLUE LIGHT IRRADIATED AND TREATED WITH BICOALGAE ω3


Figure 2: Visualisation of ROS in fluorescent marked skin explants


180 160 140 120 100 80 60 40 20 0


Control


Not irradiated Not Treated


Control


Blue light irradiated Not Treated


on decreasing pro-inflammatory cytokines. Constant release of ROS and pro-


-78%


Blue light irradiated and treated with Bicoalgae ω3


Figure 3: Quantification of ROS in the skin


in microalgae N. gaditana and I. galbana, respectfully. These have an impact on skin processes such as inflammatory conditions. EPA and DHA are not synthesised by the human body and should be acquired from nutrition sources.


Decrease of pro-inflammatory cytokines Studies were conducted to determine the natural origin omega-3 delivery system’s effect


Stratum corneum & epidermis ■ Dermis ■ Average


ROS decrease -39%


Average


ROS decrease -124%


inflammatory cytokines characterise chronic skin inflammation, while a decrease of pro- inflammatory cytokines in inflamed tissues indicate improvement of inflamed skin. A study was conducted where non treated and treated inflamed organotypic cultures of human skin explants were put in the presence of bacterial lipopolysaccharides (LPS), which stimulate a generic skin inflammation. After 24 hours of incubation, the cytokines IL-1β and IL-8 were calculated. Treated cultures used the natural origin omega-3 delivery system at both 1% and 3%. As seen in Figure 1, the natural origin omega-3 delivery system decreased the level of the age-related pro- inflammatory cytokines IL-1β and IL-8 in inflamed skin.


Prevention of blue light-induced ROS Skin samples treated and non-treated with a cream containing 3% of the natural origin omega-3 delivery system for 24 hours were incubated for 30 minutes with dichlorofluorescein diacetate (DCFH-DA) at 40°C, a fluorescent marker that reacts with ROS. The skin samples were then irradiated with blue light (l= 468nm) for 4 hours. Samples were observed by optical microscopy using fluorescence filters to show and quantify the presence of ROS. Figure 2 is a visualisation of ROS in


fluorescent-marked skin explants where (A) is not irradiated and not treated, (B) is irradiated and not treated and (C) is irradiated and treated with the natural origin omega-3 delivery system. Green fluorescence indicates presence of ROS. When quantifying the level of ROS in the


containing microalgae extracts


Treated with cream


Treated with cream containing 3% Bicoalgae ω3


skin due to blue light irradiation, the natural origin omega-3 delivery system displayed a 78% reduction in ROS compared to the non- treated control as seen in Figure 3.


Figure 4: ROS in the skin PERSONAL CARE October 2021


UV Vis-induced oxidative stress A study was performed to demonstrate that the natural origin omega-3 delivery system leverages Bicosome technology to allow for the targeted delivery of the microalgae actives, increasing the efficacy of the N. gaditana and I. galbana extracts in the stratum corneum, epidermis, and dermis areas.


www.personalcaremagazine.com


Fluorescence intensity (AU)


Fluorescence intensity /AU


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92